Alight reported second-quarter results on August 4, 2026 that beat the modest expectations Wall Street had built, yet the headline picture remains one of a shrinking, heavily indebted business. Revenue for the quarter ended June 30 came in at $511 million, down 3.2% from $528 million a year earlier, while adjusted EBITDA, the company's preferred cash-profit gauge, fell to $92 million from $127 million, a margin decline from 24.1% to 18.0%. The one unambiguously positive line is cash: the business generated $101 million of free cash flow in the first half, and management points to client-service functions being brought back in-house and early traction from an AI-led modernization effort as the foundation for a longer-term return to profitable growth.
The thesis is that Alight is a battered but still-cash-generative franchise whose depressed valuation already prices in further decline. At roughly $13.84 per share the equity carries a market value of only about $375 million, which stands against a net debt position of $1,781 million, so the company is effectively being valued as a near-insolvent business despite throwing off over $200 million of annualized free cash flow. Management raised its full-year adjusted EBITDA guidance range slightly while narrowing revenue guidance, and the stock has stabilized after a brutal stretch that included a $3.1 billion goodwill write-down in 2025, a 1-for-20 reverse stock split in June 2026, and the arrival of a new chief executive from the insurance sector.
The single load-bearing risk is the capital structure, not the operations. With roughly $2.0 billion of term-loan debt maturing in 2028 and a tax receivable agreement that continues to demand cash, the equity has little margin for error if the revenue decline accelerates or margins compress further. The falsifiable clock is the third-quarter print, expected in early November, where management has guided revenue of $469 million to $479 million and adjusted EBITDA of $55 million to $61 million; that quarter, with its heavy seasonality and the lingering effects of weak 2025 commercial execution, is the first real test of whether the current-year guidance is achievable.